Manoj Kumar Pandey joined Cooper Medical School of Rowan University in August 2016 as an Assistant Professor of Biomedical Sciences. Before his appointment, he was an Assistant Professor of Pharmacology at Pennsylvania State University College of Medicine, Hershey, PA. He earned his Ph.D. in Biochemistry from the Indian Institute of Toxicology Research (IITR) and Lucknow University, India. Afterward, he accomplished his postdoctoral training at UT MD Anderson Cancer Center, Houston, TX. He is a member of the American Association of Cancer Research and the American Society of Hematology. He is a recipient of the Brian D. Novis Research Award from the International Myeloma Foundation and the Ramalinga Swami Fellowship from the Indian Government. The central theme of his research is the study and targeting of tumor microenvironments for cancer prevention and treatment. Specifically, the laboratory is actively engaged in understanding/targeting key inflammatory mediators, using functional genomic and proteomic technologies to better understand and target the bone marrow microenvironment in the treatment of Multiple Myeloma, and targeting myeloma stem cells and bone marrow stromal cells for control of bone loss.